“Dr. Path Labs Set to Expand into Tier 3 & 4 Markets, Bringing Advanced Diagnostics to Underserved Regions”
Dr. Path Labs Announces Expansion into Tier 3 and 4 Markets Dr Lal Path Labs, a leading diagnostic service provider,…
SwasthFit
Read More
October 30, 2026
- Maharashtra Nurses Federation Demands Inquiry into GNM Exam Irregularities, Announces Protest on October 30
- NPPA Revises Prices of 543 Anti-Cancer Medicine Brands, New Rates Effective November 9
- Blood Bank Licensing Goes Fully Digital, Approval Timeline Reduced to Four Months
- UP Cabinet Approves PPP Model for Four Government Hospitals, Including Bareilly’s 300-Bed Facility